期刊文献+

塞来昔布用于下颌阻生牙拔除术后镇痛的疗效评价 被引量:4

Application of celecoxib in analgesia for patients who underwent extraction of impacted tooth
下载PDF
导出
摘要 目的:评价塞来昔布对下颌阻生牙拔除术后急性疼痛的镇痛效果。方法 :90例拔除下颌阻生第三磨牙的患者按随机双盲法分为塞来昔布组、布洛芬组、安慰剂组,每组30例。拔牙4 h后,分别给予塞来昔布400 mg、布洛芬400 mg、维生素C 100 mg。采用视觉模拟评分法(visual analogue scale,VAS),记录患者拔牙4 h后、服药24 h内的疼痛情况及不良反应,利用SPSS 13.0软件包,通过χ2检验和方差分析,比较2种药物的镇痛效果有无显著差异。结果:塞来昔布组、布洛芬组与安慰剂组相比,在镇痛药起效时间、疼痛强度差值(PID)、疼痛缓解程度(PAR)、总疼痛强度差(SPID)、疼痛缓解总和(TOPPAR)、整体评价方面具有显著差异(P<0.05)。塞来昔布组与布洛芬组相比,镇痛效果基本相同,仅服药12 h后两者的PID有显著差异(P<0.05)。服药24 h内,在镇痛起效时间、PAR、SPID、TOPPAR、整体评价方面的差异无显著性(P>0.05)。结论:塞来昔布对下颌阻生牙拔除术后中、重度急性疼痛有明显的镇痛作用。 PURPOSE: To evaluate the effect of celecoxib in acute pain relief after extraction of impacted tooth. METHODS: In the randomized, double-blind placebo-controlled trial, 90 patients who underwent extraction of impacted mandibular third molar, were divided into 3 groups based on the use of ccelecoxib, ibuprofen and placebo. Each group had 30 patients. After 4 hours of extraction, patients were given 400 mg celecoxib in the celecoxib group, 400 mg ibuprofen in the ibuprofen group. While in the placebo group, 100 mg vitamin C was administrated. Pain and adverse events were recorded after extraction and application of 3 drugs. Chi-square test and analysis of variance were carried out for comparison between the three groups using SPSS 13.0 software package. RESULTS: There were significant differences in analgesic onset time, PID, PAR, SPID, TOPPAR and overall assessment between celecoxib group, ibuprofen and placebo group (P〈0.05). Compared with celecoxib group and ibuprofen group, the analgesic effect was quite the same. 12 h after administration, only the PID of the two groups had significant difference (P〈0.05). Within 24 h, there was no significant difference in time to onset of analgesia, PAR, SPID, TOPPAR, and overall assessment (P〉0.05). CONCLUSIONS: Celecoxib has distinct analgesic effect in extraction of impacted teeth with acute severe pain.
出处 《中国口腔颌面外科杂志》 CAS 2014年第1期65-68,共4页 China Journal of Oral and Maxillofacial Surgery
基金 广东省科技社会发展项目(2012B031800374)~~
关键词 塞来昔布 阻生牙 拔牙 镇痛 Celecoxib Impacted tooth Extraction Analgesia
  • 相关文献

参考文献14

  • 1Lanas A. A review of the gastrointestinal safety data--a gastroenterologist's perspective[J].Rheumatol (Oxford),2010,(Suppl 2):ii3-i10.
  • 2王永,蒋宗滨,杨学著,张明明,张夏,黄子津,杨冯睿.塞来昔布对腹腔镜手术术后镇痛的临床研究[J].实用疼痛学杂志,2007,3(6):431-434. 被引量:8
  • 3叶坪,寇伯龙,张斌.塞来昔布在髋膝关节置换手术后多模式镇痛的应用[J].中华临床医师杂志(电子版),2011,5(3):153-155. 被引量:16
  • 4Kleinert R,Lange C,Steup A. Single dose analgesic efficacy of tapentadol in postsurgical dental pain:the results of a randomized,double-blind,placebo-controlled study[J].{H}Anesthesia and Analgesia,2008,(6):2048-2055.
  • 5Fricke J,Davis N,Yu V. Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery:a randomized,controlled trial[J].{H}Journal of Pain,2008,(1):20-27.
  • 6Black P,Max MB,Desjardins P. A randomized,doubleblind,placebo-controlled comparison of the analgesic efficacy,onset of action,and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain[J].{H}Clinical Therapeutice,2002,(7):1072-1089.
  • 7Gbotolorun OM,Arotiba GT. Ladeinde AL Assessment of factors associated with surgical difficulty in impacted mandibular third molar extraction[J].{H}Journal of Oral and Maxillofacial Surgery,2007,(10):1977-1983.
  • 8Lago-Méndez L,Diniz-Freitas M,Senra-Rivera C. Relationships between surgical difficulty and postoperative pain in lower third molar extractions[J].{H}Journal of Oral and Maxillofacial Surgery,2007,(5):979-983.
  • 9魏魁杰,赵立星.氯诺昔康在下颌阻生智牙拔除术后镇痛中的应用[J].中国口腔颌面外科杂志,2005,3(2):145-147. 被引量:3
  • 10Becker DE. Pain management:part 1:managing acute and postoperative dental pain[J].{H}Anesthesia Progress,2010,(2):67-78.

二级参考文献24

  • 1[1]Pruss TP, Stroissnig H, Radhofer-Welte S, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam [J]. Postgrad Med J, 1990, 66 (Suppl 4):518-521.
  • 2[2]Berry H, Bird HA, Black C, et al. A double blind, multicenter,placebo controlled trail of lornoxicam in patients with osteoarthritis of the hip and knee [J]. Ann Rheum Dis, 1992, 51(2): 238-242.
  • 3[3]Kullich W, Klein G. Influence of the nonsteroidal anti-inflammatory drug lornoxicam on the secretion of the endogenous opiate peptides dynorphin and β-endorphin [J]. Aktuel Rheumatol, 1992,17(2): 128-132.
  • 4[5]Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam.A short half-life oxicam [J]. Clin Pharmacokinet, 1998, 34(6):421-428.
  • 5[6]Berg J, Christoph T, Widerna M, et al. Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line [J]. J Pharmacol Toxicol Methods, 1997, 37(4): 179-186.
  • 6[1]American Pain Society Quality Improvement Committee.JAMA,1995,1847 -1880.
  • 7[2]Joint Commission on Accreditation of Healthcare Organizations.Jt Comm Perspect,1999,19 (5):6-8.
  • 8[3]Singh G,Rosen Ramey D.NSAID induced gastrointestinal complications:the ARAMIS perspective-1997.Arthritis,Rheumatism,and Aging Medical Information System.J Rheumatol Suppl,1998,51:8-16.
  • 9[4]Ong CK,Lirk P,Seymour RA,et al.The efficacy of preemptive analgesia for acute postoperative pain management:a meta-analysis.Anesth Analg,2005,100(3):757-773.
  • 10[5]Frenchs JA,Janis LR.Preemptive analgesia in foot and ankle surgery.Clin Pediatr Med Surg,2003,20 (2):237-256.

共引文献24

同被引文献23

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部